KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,062,735 | -13.8% | 116,528 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,232,866 | -13.5% | 116,528 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $1,425,137 | -1.5% | 116,528 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,446,112 | +1.1% | 116,528 | +11.2% | 0.00% | -25.0% |
| Q3 2022 | $1,431,000 | +3.6% | 104,752 | +39.1% | 0.00% | +33.3% |
| Q2 2022 | $1,381,000 | +1353.7% | 75,326 | +1181.1% | 0.00% | – |
| Q1 2022 | $95,000 | +15.9% | 5,880 | 0.0% | 0.00% | – |
| Q4 2021 | $82,000 | -91.8% | 5,880 | -83.4% | 0.00% | -100.0% |
| Q1 2021 | $999,000 | -13.4% | 35,339 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $1,154,000 | -11.4% | 35,339 | -16.8% | 0.00% | 0.0% |
| Q3 2020 | $1,302,000 | +1872.7% | 42,489 | +539.2% | 0.00% | – |
| Q1 2020 | $66,000 | -63.9% | 6,647 | -50.0% | 0.00% | – |
| Q4 2019 | $183,000 | – | 13,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |